 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 2 | 3 | | 1981 | 1 | 1 | 2 | | 1982 | 1 | 1 | 2 | | 1983 | 1 | 2 | 3 | | 1985 | 1 | 4 | 5 | | 1986 | 3 | 2 | 5 | | 1987 | 3 | 2 | 5 | | 1988 | 3 | 1 | 4 | | 1989 | 1 | 1 | 2 | | 1990 | 2 | 1 | 3 | | 1991 | 3 | 1 | 4 | | 1992 | 2 | 0 | 2 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 1 | 1 | | 1995 | 2 | 2 | 4 | | 1996 | 1 | 3 | 4 | | 1997 | 1 | 1 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 3 | 2 | 5 | | 2000 | 2 | 3 | 5 | | 2001 | 0 | 4 | 4 | | 2002 | 3 | 2 | 5 | | 2003 | 1 | 5 | 6 | | 2005 | 1 | 4 | 5 | | 2006 | 0 | 4 | 4 | | 2007 | 3 | 4 | 7 | | 2008 | 1 | 5 | 6 | | 2009 | 4 | 2 | 6 | | 2010 | 3 | 0 | 3 | | 2011 | 6 | 8 | 14 | | 2012 | 4 | 6 | 10 | | 2013 | 8 | 2 | 10 | | 2014 | 2 | 6 | 8 | | 2015 | 7 | 5 | 12 | | 2016 | 9 | 3 | 12 | | 2017 | 2 | 2 | 4 | | 2018 | 5 | 3 | 8 | | 2019 | 6 | 4 | 10 | | 2020 | 4 | 8 | 12 | | 2021 | 4 | 9 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
McDade TW, Demonbreun AR, Sancilio A, Mustanski B, D'Aquila RT, McNally EM. Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history. Sci Rep. 2021 08 30; 11(1):17325.
-
Sancilio AE, D'Aquila RT, McNally EM, Velez MP, Ison MG, Demonbreun AR, McDade TW. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples. Sci Rep. 2021 07 28; 11(1):15321.
-
Guthmiller JJ, Han J, Li L, Freyn AW, Liu STH, Stovicek O, Stamper CT, Dugan HL, Tepora ME, Utset HA, Bitar DJ, Hamel NJ, Changrob S, Zheng NY, Huang M, Krammer F, Nachbagauer R, Palese P, Ward AB, Wilson PC. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Sci Transl Med. 2021 06 02; 13(596).
-
Guthmiller JJ, Utset HA, Wilson PC. B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat. Viruses. 2021 05 22; 13(6).
-
Demonbreun AR, McDade TW, Pesce L, Vaught LA, Reiser NL, Bogdanovic E, Velez MP, Hsieh RR, Simons LM, Saber R, Ryan DT, Ison MG, Hultquist JF, Wilkins JT, D'Aquila RT, Mustanski B, McNally EM. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight. 2021 05 10; 6(9).
-
Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, Nelson CA, Dai YN, Hall PD, Jedrzejczak RP, Joachimiak A, Krammer F, Diamond MS, Fremont DH, Kawaoka Y, Wilson PC. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.
-
El Jaddaoui I, Allali M, Raoui S, Sehli S, Habib N, Chaouni B, Al Idrissi N, Benslima N, Maher W, Benrahma H, Hamamouch N, El Bissati K, El Kasmi S, Hamdi S, Bakri Y, Nejjari C, Amzazi S, Ghazal H. A review on current diagnostic techniques for COVID-19. Expert Rev Mol Diagn. 2021 02; 21(2):141-160.
-
Higgins RL, Rawlings SA, Case J, Lee FY, Chan CW, Barrick B, Burger ZC, Yeo KJ, Marrinucci D. Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay. PLoS One. 2021; 16(3):e0247797.
-
Yi X, Chan CW, Yeo KJ. Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening? Am J Clin Pathol. 2021 02 11; 155(3):321-323.
-
Chan CW, Shahul S, Coleman C, Tesic V, Parker K, Yeo KJ. Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection. Am J Clin Pathol. 2021 02 04; 155(2):286-295.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|